A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease

S. Terada (Nara, Japan), T. Hajiro (Nara, Japan), H. Yutani (Nara, Japan), M. Ueyama (Nara, Japan), T. Nakanishi (Nara, Japan), N. Hamao (Nara, Japan), T. Inao (Nara, Japan), Y. Kaji (Nara, Japan), T. Yasuda (Nara, Japan), S. Hashimoto (Nara, Japan), E. Tanaka (Nara, Japan), Y. Taguchi (Nara, Japan)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session: CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type: Poster Discussion
Number: 3668
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Terada (Nara, Japan), T. Hajiro (Nara, Japan), H. Yutani (Nara, Japan), M. Ueyama (Nara, Japan), T. Nakanishi (Nara, Japan), N. Hamao (Nara, Japan), T. Inao (Nara, Japan), Y. Kaji (Nara, Japan), T. Yasuda (Nara, Japan), S. Hashimoto (Nara, Japan), E. Tanaka (Nara, Japan), Y. Taguchi (Nara, Japan). A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease. 3668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


The Asian experience in co-existing lung cancer and interstitial lung disease
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


A case study of oligometastatic lung adenocarcinoma
Source: International Congress 2015 – Lung cancer: the need for a multidisciplinary approach - an interactive session
Year: 2015



Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017
Year: 2017



Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Drug-induced infiltrative lung disease
Source: Eur Respir J 2001; 18: 93S-100S
Year: 2001



Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019

A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



How to treat lung cancer in IPF patients
Source: Research Seminar 2015
Year: 2015

The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Prevalence and characterization of interstitial lung disease in a lung cancer screening program
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Bilateral lung cancer with COPD or metastatic disease
Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology
Year: 2016



Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008



Interstitial lung diseases in a lung cancer screening trial
Source: Eur Respir J 2011; 38: 392-400
Year: 2011